U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Tue Apr 01 16:23:54 GMT 2025
Edited
by admin
on Tue Apr 01 16:23:54 GMT 2025
Protein Sub Type
Sequence Origin VIRAL
Sequence Type COMPLETE
Record UNII
31830Y299X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
REACTION PRODUCTS OF BACTERIOPHAGE Q-BETA COAT PROTEIN WITH HUMAN .BETA.-AMYLOID PROTEIN-(1-6)-PEPTIDYLGLYCYLGLYCYL-L-CYSTEINE AND 3-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROLE-1-YL)-N-(6-((2,5-DIOXOPYRROLIDIN-1-YL)OXY)-6-OXOHEXYL)PROPANAMIDE
Preferred Name English
AMILOMOTIDE
INN  
INN  
Official Name English
amilomotide [INN]
Common Name English
CAD-106
Code English
VIRUS LIKE PARTICLE OF BACTERIOPHAGE Q-BETA COAT PROTEIN THAT IS COUPLED TO MULTIPLE COPIES OF HUMAN BETA-AMYLOID1-6 PEPTIDE FRAGMENT
Common Name English
CAD106
Code English
Code System Code Type Description
NCI_THESAURUS
C166623
Created by admin on Tue Apr 01 16:23:54 GMT 2025 , Edited by admin on Tue Apr 01 16:23:54 GMT 2025
PRIMARY
INN
9490
Created by admin on Tue Apr 01 16:23:54 GMT 2025 , Edited by admin on Tue Apr 01 16:23:54 GMT 2025
PRIMARY
DRUG BANK
DB05150
Created by admin on Tue Apr 01 16:23:54 GMT 2025 , Edited by admin on Tue Apr 01 16:23:54 GMT 2025
PRIMARY
SMS_ID
300000025253
Created by admin on Tue Apr 01 16:23:54 GMT 2025 , Edited by admin on Tue Apr 01 16:23:54 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108328
Created by admin on Tue Apr 01 16:23:54 GMT 2025 , Edited by admin on Tue Apr 01 16:23:54 GMT 2025
PRIMARY
FDA UNII
31830Y299X
Created by admin on Tue Apr 01 16:23:54 GMT 2025 , Edited by admin on Tue Apr 01 16:23:54 GMT 2025
PRIMARY
CAS
1238372-23-0
Created by admin on Tue Apr 01 16:23:54 GMT 2025 , Edited by admin on Tue Apr 01 16:23:54 GMT 2025
PRIMARY
From To
1_74 1_80
Related Record Type Details
HUMAN .BETA.-AMYLOID PEPTIDE (1-42) PROTOFIBRILS
TARGET->VACCINE ANTIGEN
Related Record Type Details
AMILOMOTIDE
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
VIRAL CAPSID Amount: UNSPECIFIED SUBSTANCE
6e08b726
(not in database)
AMINO ACID SUBSTITUTION LYSINE Amount: .BETA.-AMYLOID PROTEIN-(1-6)-PEPTIDYLGLYCYLGLYCYL-L-CYSTEINE-3-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROLE-1-YL)-N-(6-((2,5-DIOXOPYRROLIDIN-1-YL)OXY)-6-OXOHEXYL)PROPANAMIDE-LYSINE VXW55WQ4I6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966